Clorox (CLX) reported fiscal Q2 adjusted earnings late Monday of $1.55 per diluted share, down from $2.16 a year earlier.

Analysts surveyed by FactSet expected $1.40.

Sales for the quarter ended Dec. 31 were $1.69 billion, down from $1.99 billion a year earlier.

Analysts polled by FactSet expected $1.63 billion.

The company expects fiscal year 2025 adjusted earnings of $6.95 to $7.35 per diluted share, compared with its prior outlook of $6.65 to $6.90. Analysts surveyed by FactSet expect $6.86.

The company expects net sales for the year to be down 1% to up 2%, versus its previous outlook for a decline of mid- to high-single digits. Analysts surveyed by FactSet expect $7.05 billion.